Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: One year of follow-up

Acta Ophthalmologica

Volumn 89, Issue 7, 2011, Pages 641-646

  El Matri, Leila ^a   Kort, Fedra ^a   Bouraoui, Rim ^a   Karim, Baklouti ^a   Chebil, Ahmed ^a   Chaker, Nibrass ^a  

^a Institut Hedi Rais d'Ophtalmologie   (Tunisia)

Author keywords

angioid streaks; bevacizumab; choroidal neovascularization

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ANGIOID STREAK; ARTICLE; CENTRAL RETINAL THICKNESS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINA TEAR; RETREATMENT; RETROSPECTIVE STUDY; SLIT LAMP; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; ANGIOGENESIS INHIBITORS; ANGIOID STREAKS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETINA; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; YOUNG ADULT;

EID: 80155201147     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01836.x     Document Type: Article

References (20)

1. Avery RL, Pieramici DJ, Rabena MD, et al., (2006): Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363-372.
2. Bhatnagar P, Freund KB, Spaide RF, et al., (2007): Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 27: 897-902. (Pubitemid 47479384)
3. Bonnin P, Pournaras JA, Lazrak Z, et al., (2010): Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin) in neovascular age-related macular degeneration. Acta Ophthalmol 88: 641-645.
4. Browning AC, Chung AK, Ghanchi F, et al., (2005): Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 112: 1227-1231. (Pubitemid 40916929)
5. Browning AC, Amoaku WM, Chung AK, et al., (2007): Photodynamic therapy for angioid streaks. Ophthalmology 114: 1592.
6. Chang LK, Spaide R, Brue C, et al., (2008): Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Arch Ophthalmol 126: 941-945. (Pubitemid 352008374)
7. Donati C, Virgili G, Bini A, et al., (2009): Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series. Ophthalmologica 223: 24-27.
8. Fernando J, Fromow-Guerra J, Sanchez JG, et al., (2008): Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration. Results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Retina 28: 1051-1060.
9. Finger RP, Charbel IssaP, Ladewig M, et al., (2008): Intravitreal bevacizumab for choroidal neovascularization associated with pseudowanthomann elasticum. Br J Ophthalmol 92: 483-487. (Pubitemid 351497973)
10. Gomi F, Nishida K, Oshima Y, et al., (2007): Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone. Am J Ophthalmol 143: 507-509.
11. Ikuno Y, Sayanagi K, Soga K, et al., (2009): Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol 147: 94-100.
12. Laud K, Spaide RF, Freund KB, et al., (2006): Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab. Retina 26: 960-963. (Pubitemid 44547453)
13. Levy J, Shneck M, Rosen S, et al., (2008): Intravitreal bevacizumab (Avastin) for subfoveal neovascular age-related macular degeneration. Int Ophthalmol 28: 148-153.
14. Menchini U, Virgili G, Introini U, et al., (2004): Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina 24: 763-771. (Pubitemid 39391769)
15. Neri P, Salvolini S, Mariotti C, et al., (2009): Long-term control of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab (Avastin). Br J Ophthalmol 93: 155-158.
16. Rinaldi M, Dell'Omo R, Romano M, et al., (2007): Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 125: 1422-1423. (Pubitemid 47606613)
17. Sawa M, Gomi F, Tsujikawa M, et al., (2009): Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Am J Ophthalmol 148: 584-590.
18. Shaikh S, Ruby AJ, Williams GA, et al., (2003): Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol 135: 1-6. (Pubitemid 36020416)
19. Wiegand TW, Rogers AH, Mc CabeF, et al., (2009): Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks. Br J Ophthalmol 93: 47-51.
20. Wong TY, Liew G, &, Mitchell P, (2007): Clinical update: new treatments for age-related macular degeneration. Lancet 370: 204-206. (Pubitemid 47069522)